981 related articles for article (PubMed ID: 26049087)
1. Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease.
Koronyo Y; Salumbides BC; Sheyn J; Pelissier L; Li S; Ljubimov V; Moyseyev M; Daley D; Fuchs DT; Pham M; Black KL; Rentsendorj A; Koronyo-Hamaoui M
Brain; 2015 Aug; 138(Pt 8):2399-422. PubMed ID: 26049087
[TBL] [Abstract][Full Text] [Related]
2. Peripherally derived angiotensin converting enzyme-enhanced macrophages alleviate Alzheimer-related disease.
Koronyo-Hamaoui M; Sheyn J; Hayden EY; Li S; Fuchs DT; Regis GC; Lopes DHJ; Black KL; Bernstein KE; Teplow DB; Fuchs S; Koronyo Y; Rentsendorj A
Brain; 2020 Jan; 143(1):336-358. PubMed ID: 31794021
[TBL] [Abstract][Full Text] [Related]
3. A novel role for osteopontin in macrophage-mediated amyloid-β clearance in Alzheimer's models.
Rentsendorj A; Sheyn J; Fuchs DT; Daley D; Salumbides BC; Schubloom HE; Hart NJ; Li S; Hayden EY; Teplow DB; Black KL; Koronyo Y; Koronyo-Hamaoui M
Brain Behav Immun; 2018 Jan; 67():163-180. PubMed ID: 28860067
[TBL] [Abstract][Full Text] [Related]
4. Myeloid differentiation factor 88-deficient bone marrow cells improve Alzheimer's disease-related symptoms and pathology.
Hao W; Liu Y; Liu S; Walter S; Grimm MO; Kiliaan AJ; Penke B; Hartmann T; Rübe CE; Menger MD; Fassbender K
Brain; 2011 Jan; 134(Pt 1):278-92. PubMed ID: 21115468
[TBL] [Abstract][Full Text] [Related]
5. Chronic Toxoplasma gondii infection enhances β-amyloid phagocytosis and clearance by recruited monocytes.
Möhle L; Israel N; Paarmann K; Krohn M; Pietkiewicz S; Müller A; Lavrik IN; Buguliskis JS; Schott BH; Schlüter D; Gundelfinger ED; Montag D; Seifert U; Pahnke J; Dunay IR
Acta Neuropathol Commun; 2016 Mar; 4():25. PubMed ID: 26984535
[TBL] [Abstract][Full Text] [Related]
6. Clearance of cerebral Aβ in Alzheimer's disease: reassessing the role of microglia and monocytes.
Zuroff L; Daley D; Black KL; Koronyo-Hamaoui M
Cell Mol Life Sci; 2017 Jun; 74(12):2167-2201. PubMed ID: 28197669
[TBL] [Abstract][Full Text] [Related]
7. Intravenous infusion of monocytes isolated from 2-week-old mice enhances clearance of Beta-amyloid plaques in an Alzheimer mouse model.
Hohsfield LA; Humpel C
PLoS One; 2015; 10(4):e0121930. PubMed ID: 25830951
[TBL] [Abstract][Full Text] [Related]
8. Bone-Marrow-Derived Microglia-Like Cells Ameliorate Brain Amyloid Pathology and Cognitive Impairment in a Mouse Model of Alzheimer's Disease.
Kawanishi S; Takata K; Itezono S; Nagayama H; Konoya S; Chisaki Y; Toda Y; Nakata S; Yano Y; Kitamura Y; Ashihara E
J Alzheimers Dis; 2018; 64(2):563-585. PubMed ID: 29914020
[TBL] [Abstract][Full Text] [Related]
9. Tau passive immunization inhibits not only tau but also Aβ pathology.
Dai CL; Tung YC; Liu F; Gong CX; Iqbal K
Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379
[TBL] [Abstract][Full Text] [Related]
10. Distinct inflammatory phenotypes of microglia and monocyte-derived macrophages in Alzheimer's disease models: effects of aging and amyloid pathology.
Martin E; Boucher C; Fontaine B; Delarasse C
Aging Cell; 2017 Feb; 16(1):27-38. PubMed ID: 27723233
[TBL] [Abstract][Full Text] [Related]
11. Methods to monitor monocytes-mediated amyloid-beta uptake and phagocytosis in the context of adjuvanted immunotherapies.
Hallé M; Tribout-Jover P; Lanteigne AM; Boulais J; St-Jean JR; Jodoin R; Girouard MP; Constantin F; Migneault A; Renaud F; Didierlaurent AM; Mallett CP; Burkhart D; Pilorget A; Palmantier R; Larocque D
J Immunol Methods; 2015 Sep; 424():64-79. PubMed ID: 26002154
[TBL] [Abstract][Full Text] [Related]
12. Activated Bone Marrow-Derived Macrophages Eradicate Alzheimer's-Related Aβ
Li S; Hayden EY; Garcia VJ; Fuchs DT; Sheyn J; Daley DA; Rentsendorj A; Torbati T; Black KL; Rutishauser U; Teplow DB; Koronyo Y; Koronyo-Hamaoui M
Front Immunol; 2020; 11():49. PubMed ID: 32082319
[TBL] [Abstract][Full Text] [Related]
13. Eliminating microglia in Alzheimer's mice prevents neuronal loss without modulating amyloid-β pathology.
Spangenberg EE; Lee RJ; Najafi AR; Rice RA; Elmore MR; Blurton-Jones M; West BL; Green KN
Brain; 2016 Apr; 139(Pt 4):1265-81. PubMed ID: 26921617
[TBL] [Abstract][Full Text] [Related]
14. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
15. Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer's disease.
Sosna J; Philipp S; Albay R; Reyes-Ruiz JM; Baglietto-Vargas D; LaFerla FM; Glabe CG
Mol Neurodegener; 2018 Mar; 13(1):11. PubMed ID: 29490706
[TBL] [Abstract][Full Text] [Related]
16. Tissue-Plasminogen Activator Attenuates Alzheimer's Disease-Related Pathology Development in APPswe/PS1 Mice.
ElAli A; Bordeleau M; Thériault P; Filali M; Lampron A; Rivest S
Neuropsychopharmacology; 2016 Apr; 41(5):1297-307. PubMed ID: 26349911
[TBL] [Abstract][Full Text] [Related]
17. Cytokine-producing microglia have an altered beta-amyloid load in aged APP/PS1 Tg mice.
Babcock AA; Ilkjær L; Clausen BH; Villadsen B; Dissing-Olesen L; Bendixen AT; Lyck L; Lambertsen KL; Finsen B
Brain Behav Immun; 2015 Aug; 48():86-101. PubMed ID: 25774009
[TBL] [Abstract][Full Text] [Related]
18. Comparative studies using the Morris water maze to assess spatial memory deficits in two transgenic mouse models of Alzheimer's disease.
Edwards SR; Hamlin AS; Marks N; Coulson EJ; Smith MT
Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):798-806. PubMed ID: 25115283
[TBL] [Abstract][Full Text] [Related]
19. Microglial response to LPS increases in wild-type mice during aging but diminishes in an Alzheimer's mouse model: Implication of TLR4 signaling in disease progression.
Go M; Kou J; Lim JE; Yang J; Fukuchi KI
Biochem Biophys Res Commun; 2016 Oct; 479(2):331-337. PubMed ID: 27641666
[TBL] [Abstract][Full Text] [Related]
20. The neuroprotective effects of Cerebrolysin in a transgenic model of Alzheimer's disease are associated with improved behavioral performance.
Rockenstein E; Adame A; Mante M; Moessler H; Windisch M; Masliah E
J Neural Transm (Vienna); 2003 Nov; 110(11):1313-27. PubMed ID: 14628195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
